PTC Therapeutics(PTCT)
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Quarterly
Quarterly
Annual
Annual
*Quarterly sales USD (in millions)
Global
US
Rest of World
Drug
Year
Quarter
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Emflaza | Deflazacort | 2017-02-09 | ||
| Translarna | Ataluren | 2014-07-31 | ||
| Upstaza | Eladocagene exuparvovec | 2022-07-18 |
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use